Лейкоз / лимфома Беркитта: клинические особенности, диагностические критерии, терапевтическая тактика Е. А. Барях, С. К. Кравченко, А. М. Кременецкая, Е. Е. Звонков, А. У. Магомедова, Т. Н. Обухова, Ю. Ю. Попова, О. С. Финк, Г. А. Клясова, Е. М. Шулутко, Г. М. Галстян, И. Б. Капланская, И. А. Воробьев, А. И. Воробьев
Elena Alexandrovna Baryakh, С К Кравченко, Aleksandra Mikhaylovna Kremenetskaya et al. · CyberLeninK (CyberLeninka) · 2010
SUMMARY Burkitt lymphoma (BL) is the most aggressive B-cell lymphoid neoplasm, which growth phase fraction approximates 100 %. BL has specific chromosomal abnormalities: (8;14)(q24;q32), rare — t(2;8)(p12;q32)or t(8;22)(q24;q11). Burkitt leukemia / BL is one of the stages of Burkitt lymphoma according to S. B. Murphy’s classification (blasts > 25 %). 23 patients with BL (with c-myc rearrangement), 15 males and 8 females, mean age 24 years (15–51) were eligible for our study performed in the Russian Hematological Research Center between 1995 and 2009. The main diagnosis criteria of BL are: translocation t(8;14)(q24;q32) or variant c-myc rearrangement, blasts in bone marrow > 25 %, young age, rapid tumor progression, bulky disease, tumor localization in abdominal and / or retro abdominal cavity, B-symptoms, increased LDG level, high number of Ki-67-positive cells approximates 100 %; CD10+, bcl-6+; sIgM+. 16 patients were included in high intensive short term protocol BL-M-04 (2003–2009). The 5-year disease-free survival was 87 % with an overall survival of 81 %. Most infectious and hemorrhagic complications occurred during the first course (course A), which can be explained by the initial poor condition of the patients. The use of this protocol can achieve rapid tumor regression with short treatment duration due to the chemotherapy intensification.
Cited by 0 works.
Authors
- Elena Alexandrovna Baryakh
- С К Кравченко
- Aleksandra Mikhaylovna Kremenetskaya
- Eugene E. Zvonkov
- А. У. Магомедова
- Обухова Татьяна Никифоровна
- Galina Aleksandrovna Klyasova
- Е М Шулутко
- Gennadii Martinovich Galstyan
- I B Kaplanskaya
- И. А. Воробьев
- Andrei Vorobjov
References
- Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults.
- Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
- Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society.
- High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
- Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
- Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
- Adult Burkitt leukemia and lymphoma
- Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
- Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
- Treatment of Burkitt's tumor with cyclophosphamide